The monoamine oxidase B gene GT repeat polymorphism and Parkinson's disease in a Chinese population

Journal of Neurology

Volumn 247, Issue 1, 2000, Pages 52-55

  Mellick, George D ^a   Buchanan, Daniel D ^a   Silburn, Peter A ^a   Chan, Daniel K Y ^b   Le Couteur, David G ^c   Law, L K ^d   Woo, J ^d   Pang, C P ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c CANBERRA HOSPITAL   (Australia)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Genetics; Monoamine oxidase B; Parkinson's disease

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; NEUROTOXIN;

ADULT; AGED; ARTICLE; CHINESE; CHROMOSOME XP; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; DOPAMINE METABOLISM; ENVIRONMENTAL FACTOR; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEREDITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0034022516     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050010     Document Type: Article

References (26)

1. 1. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD (1993) Association of monoamine oxidase B allele with Parkinson's disease. Ann Neurol 33 : 368-372
2. 2. Kurth JH, Hubble JP, Eggers EA, Kurth MC, Koller WC, Lieberman AN (1995) Lack of association of CYP2D6 and MAO-B alleles with Parkinson's disease in a Kansas cohort. Neurology 45 [Suppl 4] : A429
3. 3. Ho SL, Kapadi AL, Ramsden DB, Williams AC (1995) An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 37 : 403-405
4. 4. Costa P, Checkoway H, Swanson PD, Costa LG (1996) Monoamine oxidase B polymorphism in Parkinson's disease. Mov Disord 11 [Suppl 1] : 181
5. 5. Mellick GD, Buchanan DD, McCann SJ, et al (1999) Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mov Disord 14 : 219-224
6. 6. Konradi C, Ozelius L, Breakefield XO (1992) Highly polymorphic (GT)n repeat sequence in intron II of the human MAOB gene. Genomics 12 : 176-177
7. 7. Smith CAD, Gough AC, Leigh PN, et al (1992) Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 339 : 1375-1377
8. 8. Pang CP, Zhang J, Woo J, et al (1998) Rarity of debrisoquine hydroxylase gene polymorphism in Chinese patients with Parkinson's disease. Mov Disord 13 : 529-532
9. 9. Gasser T, Muller-Myhsok B, Supala A, et al (1996) The CYP2D6B allele is not overrepresented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 61 : 518-519
10. 10. Kosel S, Lucking CB, Egensperger R, Mehraein P, Graeber MB (1996) Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body Parkinsonism. J Neurosci Res 44 : 174-183
11. 11. Douglas AM, Georgalis AM, Benton LR, Canavan KL, Atchison BA (1992) Purification of human leukocyte DNA: proteinase K is not necessary. Anal Biochem 201 : 362-365
12. 12. LeCouteur DG, Leighton PW, McCann SJ, Pond SM (1997) Association of a polymorphism in the dopamine transporter with Parkinson's disease. Mov Disord 12 : 760-763
13. 13. Leighton PW, LeCouteur DG, Pang CCP, et al (1997) The dopamine transporter gene and Parkinson's disease in a Chinese population. Neurology 49 : 1577-1579
14. 14. Tol HHM van, Wu CM, Guan HC, et al (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358 : 149-152
15. 15. Seaman P, Guan HC, van Tol HHM, Niznik HB (1993) Low density of dopamine D4 receptors in Parkinson's, schizophrenia and control brain striata. Synapse 14 : 247-253
16. 16. Wan DCC, Law LK, Ip DTM, et al (1999) Lack of allelic association of dopamine D4 receptor gene polymorphism with Parkinson's disease in Chinese population. Mov Disord 14: 225-229
17. 17. McCann SJ, Pond SM, James KM, LeCouteur DG (1997) Association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis. J Neurol Sci 153 : 50-53
18. 18. Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y (1993) A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J Biochem (Tokyo) 114 : 263-266
19. 19. Chan DKY, Woo J, Ho SC, et al (1998) Genetic and environmental risk factors for Parkinson's disease in a Chinese population. J Neurol Neurosurg Psychiatry 65: 781-784
20. 20. Bordet R, Broly F, Destee A, Libersa C (1996) Debrisoquine hydroxylation genotype in familial forms of idiopathic Parkinson's disease. Adv Neurol 36 : 387-396
21. 21. Waring RH, Sturman SG, Smith MCG, Steventon GB, Heafield MTE, Williams AC (1989) S-Methylation in motor neuron disease and Parkinson's disease. Lancet II : 356-357
22. 22. Nakagawa-Hattori Y, Hattori T, Kondo T, Mizuno Y (1995) S-methylation in Parkinson's disease. Neurology 45 : 2279-2280
23. 23. Langston JW (1996) The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology 47 [Suppl 3] : S153-S160
24. 24. Hutton M, Lendon CL, Rizzu P, et al (1998) Association of missense and 5′-splice-site mutations in tau with the inherited demetia FTDP-17. Nature 393 : 702-705
25. 25. Krontiris TG (1995) Minisatellites and human disease. Science 269 : 1682-1683
26. 26. Epplen JT, Kyas A, Maueler W (1996) Genomic simple repetitive DNAs are targets for differential binding of nuclear proteins. FEBS Lett 389 : 92-95